Your browser doesn't support javascript.
loading
Efficacy of PBTZ169 and pretomanid against Mycobacterium avium, Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum in BALB/c mice models.
Zheng, Luyao; Qi, Xueting; Zhang, Weiyan; Wang, Hong; Fu, Lei; Wang, Bin; Chen, Xi; Chen, Xiaoyou; Lu, Yu.
Afiliação
  • Zheng L; Department of Pharmacology, Beijing Key Laboratory of Drug Resistance Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, Beijing, China.
  • Qi X; Department of Pharmacology, Beijing Key Laboratory of Drug Resistance Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, Beijing, China.
  • Zhang W; Department of Pharmacology, Beijing Key Laboratory of Drug Resistance Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, Beijing, China.
  • Wang H; Department of Pharmacology, Beijing Key Laboratory of Drug Resistance Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, Beijing, China.
  • Fu L; Department of Pharmacology, Beijing Key Laboratory of Drug Resistance Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, Beijing, China.
  • Wang B; Department of Pharmacology, Beijing Key Laboratory of Drug Resistance Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, Beijing, China.
  • Chen X; Department of Pharmacology, Beijing Key Laboratory of Drug Resistance Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, Beijing, China.
  • Chen X; Tuberculosis Department, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, Beijing, China.
  • Lu Y; Infectious Diseases Department, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Front Cell Infect Microbiol ; 13: 1115530, 2023.
Article em En | MEDLINE | ID: mdl-37077530

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mycobacterium chelonae / Mycobacterium fortuitum / Mycobacterium abscessus / Infecções por Mycobacterium / Infecções por Mycobacterium não Tuberculosas Limite: Animals Idioma: En Revista: Front Cell Infect Microbiol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mycobacterium chelonae / Mycobacterium fortuitum / Mycobacterium abscessus / Infecções por Mycobacterium / Infecções por Mycobacterium não Tuberculosas Limite: Animals Idioma: En Revista: Front Cell Infect Microbiol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Suíça